Also Cyp has treated 165 patients in Osteoarthritis without generating an adverse event worthy of reporting. And these 165 patients received multiple injections. So we’re looking at close to 400 doses of Cymerus cells without triggering an event that would halt recruitment.
Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-41
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.005(2.33%) |
Mkt cap ! $47.30M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.0¢ | $27.90K | 131.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6269 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 14247 | 1 |
View Market Depth
| Last trade - 13.34pm 25/12/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
